31 Results for "

nitrile

" in MedChemExpress (MCE) Product Catalog:
Products (31)

31 Results for "nitrile" in MCE Product Catalog:

Cat. No.: HY-E70919A
Research Areas:  

Metabolic Disease

Nitrile hydratase, Rhodopseudomonas palustris (EC 4.2.1.84) is a mononuclear iron or non-corrinoid cobalt enzyme that catalyse the hydration of diverse nitriles to their corresponding amides.
loading...
    loading...
Cat. No.: HY-E70919B
Research Areas:  

Metabolic Disease

Nitrile hydratase, Rhodococcus erythropolis (EC 4.2.1.84) is a mononuclear iron or non-corrinoid cobalt enzyme that catalyse the hydration of diverse nitriles to their corresponding amides.
loading...
    loading...
Cat. No.: HY-16641
CAS No.: 1315490-71-1
Target:  

JAK

Research Areas:  

Cancer

JAK1-IN-17 (Compound 31) is a highly selective inhibitor of JAK1 with a Ki of 1.9 nM. JAK1-IN-17 exhibits a low whole blood shift, which allows maintaining good whole blood potency. JAK1-IN-17 is also a nitrile-containing analogue with consistent, yet weak reversible inhibition of CYP3A4 using a midazolam probe (IC50 = 7.9 μM). JAK1-IN-17 can be studied in cancer research .
loading...
    loading...
Cat. No.: HY-W196977
CAS No.: 67886-70-8
Synonyms: Naproxen nitrile impurity
Target:  

Drug Intermediate

Research Areas:  

Others

Naproxen impurity 6 (Naproxen Nitrile impurity) is an impurity of Naproxen.
loading...
    loading...
Cat. No.: HY-E70612
Research Areas:  

Others

Nitril hydratase can convert nitriles to the corresponding higher-value amides under mild conditions. Nitril hydratase is an important catalyst .
loading...
    loading...
Cat. No.: HY-135015
CAS No.: 629-63-0
Tetradecanenitrile is a nitrogen-containing saturated long-chain aliphatic nitrile that can be found in Pseudomonas veronii R02. Tetradecanenitrile can be used for the research of multiresistant Staphylococcus aureus infection .
loading...
    loading...
Cat. No.: HY-P2872A
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

Thioglucosidase, Sinapis alba (white mustard) seed (EC 3.2.1.147) hydrolyzes the S-glucosidic bond of a glucosinolate substrate to form an unstable aglycone that rearranges with the loss of sulfate primarily to the isothiocyanate, though thiocyanates and nitriles are also formed.
loading...
    loading...
Cat. No.: HY-Y1416R
CAS No.: 5537-71-3
Synonyms: DF2107Y (Standard)
Research Areas:  

Others

3-(1-Cyanoethyl)benzoic acid (Standard) is the analytical standard of 3-(1-Cyanoethyl)benzoic acid. This product is intended for research and analytical applications. 3-(1-Cyanoethyl)benzoic acid (DF2107Y) is a benzoic acid that can be used to screen cobalt containing nitrile hydratases (NHases) .
loading...
    loading...
Cat. No.: HY-125589
CAS No.: 1845688-96-1
Target:  

Androgen Receptor

Research Areas:  

Cancer

5N-Bicalutamide is an androgen receptor (AR) antagonist with a Ki of 0.15 nM. 5N-Bicalutamide is a derivative of Bicalutamide (HY-14249). 5N-Bicalutamide reacts with Cys784 in the AR binding pocket via an activated aryl nitrile group to form a reversible thioimidate covalent adduct, which significantly enhances its binding affinity and inhibitory potency. 5N-Bicalutamide is used in prostate cancer-related research .
loading...
    loading...
Cat. No.: HY-W761397
CAS No.: 117568-28-2
Target:  

COMT

Research Areas:  

Neurological Disease

COMT-IN-3 is a competitive inhibitor of soluble catechol-O-methyltransferase (S-COMT). COMT-IN-3 coordinates with the Mg 2+ ion at the COMT active site via its catechol hydroxyl group, and its nitro group, as a strong electron-withdrawing substituent, further enhances the binding affinity. COMT-IN-3 interacts with the hydrophobic residues Trp38, Met40, and Trp143 at the back of the active site via its neutral nitrile tail, thereby competitively inhibiting COMT activity. COMT-IN-3 can be used in research related to Parkinson's disease .
loading...
    loading...
Cat. No.: HY-L0118V
942 compounds

A unique set of molecules containing mild electrophilic moieties that covalently interact with amino acid residues in the target protein. The diversity of our compounds for covalent drug discovery ranges from natural product-like scaffolds to macrocycles, creating multiple opportunities in hit generation for a selected target.